Your trusted partner in pharmaceutical growth & global market access
Integrated support across sourcing, licensing, product registration, commercialization and pharmaceutical logistics — coordinated by one team, from first requirement to final delivery.
A dependable partner across the pharmaceutical value chain
Novapinn Pharmaceutical LLP works with pharmaceutical companies, distributors, manufacturers and business partners to provide integrated support from product identification to final delivery coordination.
More about NovapinnTrust-led partnership
Relationships built to last beyond a single transaction.
Transparent communication
Responsive coordination and status you can act on.
Domestic and international expansion
Support for market entry and growth across regulated and emerging markets.
Six areas of support, coordinated as one
Most delays in pharmaceutical market entry happen in the gaps between specialists. Novapinn closes those gaps by running all six from a single point of coordination.
Commercial Collaboration
Business development, partnerships and market expansion
Molecule & Product Sourcing
Quality sourcing with cost-conscious execution
Licensing & Partnerships
Connecting products, manufacturers and markets
Regulatory Affairs & Compliance
Registration readiness for international markets
Market Research & Entry Strategy
Practical insights before market execution
Pharmaceutical Logistics
Reliable freight forwarding for regulated cargo
A single point of coordination
For partners who need product, market, regulatory and shipment support to move faster with clarity.
Understand requirements
We start with your portfolio, target markets, timelines and constraints — so the plan is built on your reality, not a template.
Identify products & sources
Molecules, formulations and qualified manufacturers are shortlisted against commercial fit, cost and supply reliability.
Support registration
Dossier documentation, submission routes and compliance requirements are mapped and driven through to registration.
Commercialize & partner
Distributors, licensees and commercial partners are mapped, evaluated and brought to the table.
Coordinate delivery
Regulated cargo, documentation and delivery follow-up are handled so the first shipment moves as planned.
Outcome: faster market access with reduced coordination gaps and stronger execution control.
A single dependable point of support
Reliable and responsive service
A single point of contact who answers, follows up and closes loops.
Transparent communication
Status you can act on, not status you have to chase.
Quality and regulatory compliance
Compliance treated as the starting condition, not an afterthought.
Competitive and sustainable sourcing
Cost that holds up over the life of the contract, not just the first order.
Faster market access
Fewer handoffs between sourcing, regulatory and logistics means fewer delays.
End-to-end coordination
One team across product, market, regulatory and shipment.
Long-term business relationships
Built for repeat business, not transactions.
Let's build your global pharmaceutical business together
We would be pleased to understand your requirements, upcoming projects, target markets and product portfolio, and explore how Novapinn can add value to your business.
A dependable partner across the pharmaceutical value chain
Novapinn Pharmaceutical LLP works with pharmaceutical companies, distributors, manufacturers and business partners to provide integrated support from product identification to final delivery coordination.
Built around trust, transparency, reliability and mutual growth
Novapinn acts as a single point of coordination for partners who need product, market, regulatory and shipment support to move faster with clarity. Rather than adding another specialist to an already crowded chain, we take responsibility for the connections between them.
- Trust-led partnership approach
- Transparent communication and responsive coordination
- Support for domestic and international market expansion
What we do
Identify the product, source it from qualified manufacturers, drive it through registration, find the commercial partner and move the shipment — under one point of accountability.
Who we work with
Pharmaceutical companies, distributors, manufacturers and business partners expanding into new products, new territories or new commercial models.
Four things every engagement is measured against
Trust
Commitments made carefully and kept without reminders.
Transparency
Costs, timelines and risks stated plainly at the outset.
Reliability
Consistent execution across every stage of the chain.
Mutual growth
Structured so both sides gain from a long relationship.
Flexible ways to work together
Engagement is shaped around the decision in front of you, not a fixed retainer structure.
Project-based support
A defined scope with a defined outcome — a registration, a sourcing exercise, a shipment lane.
Retainer advisory
Ongoing access for portfolio, regulatory and commercial decisions as they arise.
Market entry partnerships
Joint work on entering a specific territory, from feasibility through to first launch.
Business development collaborations
Shared effort on licensing, partner search and commercial expansion.
A single dependable point of support
Reliable and responsive service
A single point of contact who answers, follows up and closes loops.
Transparent communication
Status you can act on, not status you have to chase.
Quality and regulatory compliance
Compliance treated as the starting condition, not an afterthought.
Competitive and sustainable sourcing
Cost that holds up over the life of the contract, not just the first order.
Faster market access
Fewer handoffs between sourcing, regulatory and logistics means fewer delays.
End-to-end coordination
One team across product, market, regulatory and shipment.
Long-term business relationships
Built for repeat business, not transactions.
Six areas of support, coordinated as one
Most delays in pharmaceutical market entry happen in the gaps between specialists. Novapinn closes those gaps by running all six from a single point of coordination.
Commercial Collaboration
Business development, partnerships and market expansion
Molecule & Product Sourcing
Quality sourcing with cost-conscious execution
Licensing & Partnerships
Connecting products, manufacturers and markets
Regulatory Affairs & Compliance
Registration readiness for international markets
Market Research & Entry Strategy
Practical insights before market execution
Pharmaceutical Logistics
Reliable freight forwarding for regulated cargo
Commercial Collaboration
We help partners identify new business opportunities, develop strategic partnerships and support expansion into domestic and international markets.
- Opportunity identification and prioritization
- Market entry planning and partner mapping
- Distributor and commercial network development
- Commercial coordination for sustainable growth
Commercial Collaboration
Business development, partnerships and market expansion
Molecule & Product Sourcing
Quality sourcing with cost-conscious execution
Molecule & Product Sourcing
Novapinn assists in sourcing quality APIs, intermediates, finished formulations and pharmaceutical products through qualified manufacturers and suppliers.
- API and intermediate sourcing
- Finished formulation and product sourcing
- Supplier coordination and preliminary evaluation
- Product development, costing and pricing support
Licensing & Partnerships
We connect companies with suitable products, manufacturers and market partners for licensing and portfolio expansion opportunities.
- In-licensing opportunity identification
- Out-licensing execution support
- Partner evaluation and due diligence coordination
- Contract negotiation and commercial discussion support
Licensing & Partnerships
Connecting products, manufacturers and markets
Products, partners and markets — matched
A licensing conversation only works when all three sides line up. We assess them together rather than one at a time.
Products
- Portfolio expansion
- Molecule fit
- Commercial potential
Partners
- Manufacturers
- Distributors
- Market access
Markets
- Territory strategy
- Registration route
- Launch readiness
Regulatory Affairs & Compliance
Registration readiness for international markets
Regulatory Affairs & Compliance
We support dossier documentation, regulatory submissions, product registration, lifecycle management and compliance requirements across international markets.
- Dossier preparation and submission support
- Product registration coordination
- GMP audit support and compliance readiness
- Regulatory strategy planning and follow-up
Market Research & Entry Strategy
Market entry decisions require clarity on demand, competition, regulatory route, pricing and portfolio fit — before commitments are made.
- Feasibility, demand analysis and market potential
- Competitive benchmarking and price reference
- Portfolio gap assessment
- Distributor mapping and launch planning
Market Research & Entry Strategy
Practical insights before market execution
Pharmaceutical Logistics
Reliable freight forwarding for regulated cargo
Pharmaceutical Logistics
We coordinate pharmaceutical cargo movements including temperature-sensitive and regulated shipments with proper documentation, handling, compliance and delivery follow-up.
- Temperature-sensitive cargo coordination
- Documentation and compliance support
- Shipment handling and delivery coordination
- Clear communication through the logistics cycle
Tell us the product and the market
Send the molecule, the target territory and the timeline. We will come back with the route, the likely obstacles and what it takes to move.
One point of coordination, five clear stages
Novapinn acts as a single point of coordination for partners who need product, market, regulatory and shipment support to move faster with clarity.
From requirement to delivery
Each stage hands over to the next inside the same team, so nothing is lost in translation between sourcing, regulatory and logistics.
Understand requirements
We start with your portfolio, target markets, timelines and constraints — so the plan is built on your reality, not a template.
Identify products & sources
Molecules, formulations and qualified manufacturers are shortlisted against commercial fit, cost and supply reliability.
Support registration
Dossier documentation, submission routes and compliance requirements are mapped and driven through to registration.
Commercialize & partner
Distributors, licensees and commercial partners are mapped, evaluated and brought to the table.
Coordinate delivery
Regulated cargo, documentation and delivery follow-up are handled so the first shipment moves as planned.
Outcome: faster market access with reduced coordination gaps and stronger execution control.
And how the model answers it
Handover gaps
Sourcing, regulatory and freight sitting with three unconnected parties. One coordinator removes the gap entirely.
Late regulatory surprises
Registration route assessed at the start, not after the supplier is locked and the pricing is agreed.
Unverified partners
Manufacturers and distributors evaluated before commercial discussions, not during them.
Flexible ways to work together
Project-based support
A defined scope with a defined outcome — a registration, a sourcing exercise, a shipment lane.
Retainer advisory
Ongoing access for portfolio, regulatory and commercial decisions as they arise.
Market entry partnerships
Joint work on entering a specific territory, from feasibility through to first launch.
Business development collaborations
Shared effort on licensing, partner search and commercial expansion.
Practical insights before market execution
Market entry decisions require clarity on demand, competition, regulatory route, pricing and portfolio fit — established before commitments are made.
Answered before a market is entered
Feasibility
- Demand analysis
- Market potential
- Entry viability
Competition
- Benchmarking
- Price reference
- Portfolio gaps
Execution
- Distributor mapping
- Launch planning
- Commercial pathway
A stronger market entry plan reduces delays, avoids avoidable risk and improves commercialization quality.
The regulatory route is part of the market decision
A territory that looks commercially attractive can be the wrong first move once the registration route, timeline and dossier requirements are on the table. We assess both together.
- Dossier preparation and submission support
- Product registration coordination
- GMP audit support and compliance readiness
- Regulatory strategy planning and follow-up
Compliance first
Requirements mapped at the start so the commercial plan is built on a route that actually exists.
Then the shipment
Temperature-sensitive and regulated cargo coordinated with the documentation the destination market requires.
Support for expansion in both directions
Whether you are taking a portfolio outward into new territories or bringing products into a market you already serve, the coordination problem is the same — and it is the one we solve.
Outbound
Take an existing portfolio into new territories with the registration route and distributor network mapped in advance.
Inbound
Bring in-licensed products into a market you already know, sourced from evaluated manufacturers.
Portfolio gaps
Identify what is missing from a current range and where the commercial opportunity sits.
Let's build your global pharmaceutical business together
We would be pleased to understand your requirements, upcoming projects, target markets and product portfolio, and explore how Novapinn can add value to your business.
Tell us what you are trying to move
Our team will review your message and respond as soon as possible.
Please try again or email info@novapinn.com.
Registered office
Office 101, Shivalik Satyamev, Nr. Vakil Saheb Bridge, Bopal, Ahmedabad- 380058
What happens next
- We read the requirement and come back within two working days
- A short call to confirm scope, market and timeline
- A written route with costs, obstacles and next actions
The five things that make a first reply useful
The molecule or product
API, intermediate or finished formulation — and strength or form if fixed.
The target market
One territory or several, and whether registration already exists there.
The volume
Indicative quantity or value, so sourcing can be costed realistically.
The timeline
When the product needs to be in market, and what is driving that date.
What is already done
Existing suppliers, dossiers or partners we should work with rather than replace.